FDA warns of potential side effects of powerful antibiotics

Image
AP New York
Last Updated : May 13 2016 | 9:42 PM IST
The U.S. Food and Drug Administration is ratcheting up its warning about the potential side effects of a type of commonly-prescribed powerful antibiotic often known by the brand name Cipro.
The FDA says the potential side effects of fluoroquinolone anti-bacterial drugs often outweigh their benefits when it comes to treating people with bronchitis or basic sinus or urinary tract infections.
As a result, the FDA says doctors should use these types of drugs only if they have no alternatives.
Potential serious and disabling side effects related to the drugs can include tendons, muscles and joint pain, a "pins and needles" tingling sensation, confusion and hallucinations.
The FDA issued previous warnings about the drugs in 2008 and 2013, but didn't go so far as to advise doctors to restrict their use.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 13 2016 | 9:42 PM IST

Next Story